| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |